Comparison of Low Dose Thrombolytic Therapy and Low Molecular Weight Heparin Therapy in Patients with Submassive Pulmonary Thromboembolism
(Thorac Res Pract 2019; 20: 58-58) DOI: 10.5152/TurkThoracJ.2019.58
(Thorac Res Pract 2019; 20: 58-58) DOI: 10.5152/TurkThoracJ.2019.58